FindTrial
Sign In

H. pylori eradication

DRUG4 trials

Sponsors

NTT Medical Center Tokyo, Shandong University, Soonchunhyang University Hospital

Conditions

H. Pylori InfectionH. pylori infectionHelicobacter PyloriOperative Link on Gastric Intestinal Assessmentthe Operative Link on Gastric Intestinal Metaplasia

Phase 4

The Influence of Helicobacter Pylori Eradication on Gastric Pathology: a Long-term, Prospective Cohort Study
Not yet recruitingNCT02933229
Shandong UniversityHelicobacter Pylori, Operative Link on Gastric Intestinal Assessment, the Operative Link on Gastric Intestinal Metaplasia
Start: 2016-10-31End: 2031-10-31Target: 300Updated: 2016-10-14

Unknown Phase

Impact of Helicobacter pylori eradication on insulin resistance
Active, not recruitingJPRN-UMIN000008291
NTT Medical Center TokyoH. pylori infection
Start: 2012-06-01Target: 200Updated: 2026-06-29
H. Pylori Treatment Between Modified Quadruple Regimen and Tailored Therapy
CompletedNCT05002595
Soonchunhyang University HospitalH. Pylori Infection
Start: 2018-01-01End: 2021-12-31Updated: 2022-02-24
Bismuth for PCAB-based H. Pylori Eradication
CompletedNCT05453994
Soonchunhyang University HospitalH. Pylori Infection
Start: 2020-03-01End: 2023-08-31Updated: 2023-11-22

Related Papers

Bismuth add-on improves the efficacy of 2-week tegoprazan-based triple therapy for first-line <i>Helicobacter pylori</i> eradication: a real-world evidence study
Expert Review of Anti-infective Therapy2024-03-0910 citations
Comparison of tailored <i>Helicobacter pylori</i> eradication versus modified bismuth quadruple therapy in Korea: a randomized controlled trial
Expert Review of Anti-infective Therapy2021-12-0917 citations